drugset / Trial / NCT01359254
Cord Blood Transplantation for Patients With Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to assess the rate of engraftment with combined haploidentical-cord blood transplantation in patients with pre-existing donor specific antibodies and in those with active disease.
Timeline
- Start
- 2010-04
- Primary completion
- 2011-09
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Busulfan | Small molecule | — | — |
| Subject | Melphalan | Small molecule | — | — |
| Background | ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE) | Protein / enzyme biologic | — | — |
| Background | Fludarabine | Small molecule | — | Intravenous |